Literature DB >> 28877298

Association of Intraoperative Radiotherapy in the Treatment of Early-Stage Breast Cancer With Minor Surgical Site Complications in Oncoplastic Breast-Conserving Surgery.

Angelena Crown1, Janie W Grumley1.   

Abstract

Mesh：

Year:  2017        PMID： 28877298      PMCID： PMC5831433          DOI： 10.1001/jamasurg.2017.3129

Source DB:  PubMed          Journal:  JAMA Surg        ISSN： 2168-6254            Impact factor:   14.766


× No keyword cloud information.
  5 in total

1.  Oncoplastic Breast-Conserving Surgery Reduces Mastectomy and Postoperative Re-excision Rates.

Authors:  Angelena Crown; Debra G Wechter; Janie W Grumley
Journal:  Ann Surg Oncol       Date:  2015-07-25       Impact factor: 5.344

2.  Long-Term Comparison of Aesthetical Outcomes After Oncoplastic Surgery and Lumpectomy in Breast Cancer Patients.

Authors:  Gabriela Santos; Cicero Urban; Maria Isabel Edelweiss; Gustavo Zucca-Matthes; Vilmar Marques de Oliveira; Gabriel Hubner Arana; Marco Iera; Mario Rietjens; Rubens Silveira de Lima; Cleverton Spautz; Flávia Kuroda; Karina Anselmi; Edison Capp
Journal:  Ann Surg Oncol       Date:  2014-12-18       Impact factor: 5.344

3.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

4.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.

Authors:  Umberto Veronesi; Natale Cascinelli; Luigi Mariani; Marco Greco; Roberto Saccozzi; Alberto Luini; Marisel Aguilar; Ettore Marubini
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

5.  Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

Authors:  Jayant S Vaidya; Frederik Wenz; Max Bulsara; Jeffrey S Tobias; David J Joseph; Mohammed Keshtgar; Henrik L Flyger; Samuele Massarut; Michael Alvarado; Christobel Saunders; Wolfgang Eiermann; Marinos Metaxas; Elena Sperk; Marc Sütterlin; Douglas Brown; Laura Esserman; Mario Roncadin; Alastair Thompson; John A Dewar; Helle M R Holtveg; Steffi Pigorsch; Mary Falzon; Eleanor Harris; April Matthews; Chris Brew-Graves; Ingrid Potyka; Tammy Corica; Norman R Williams; Michael Baum
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.